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Abstract
Phenotypic change is a hallmark of bacterial adaptation during chronic infection. In the case of chronic Pseudomonas
aeruginosa lung infection in patients with cystic fibrosis, well-characterized phenotypic variants include mucoid and small
colony variants (SCVs). It has previously been shown that SCVs can be reproducibly isolated from the murine lung following
the establishment of chronic infection with mucoid P. aeruginosa strain NH57388A. Using a combination of single-molecule
real-time (PacBio) and Illumina sequencing we identify a large genomic inversion in the SCV through recombination between
homologous regions of two rRNA operons and an associated truncation of one of the 16S rRNA genes and suggest this may
be the genetic switch for conversion to the SCV phenotype. This phenotypic conversion is associated with large-scale
transcriptional changes distributed throughout the genome. This global rewiring of the cellular transcriptomic output results
in changes to normally differentially regulated genes that modulate resistance to oxidative stress, central metabolism and
virulence. These changes are of clinical relevance because the appearance of SCVs during chronic infection is associated
with declining lung function.
DATA SUMMARY
All genome sequences are deposited in NCBI GenBank
under accession numbers CP013477, CP013478 and
CP013479. Transcriptome data are deposited at the EMBL-
EBI ENA database under study number PRJEB12456.
INTRODUCTION
Phenotypic variation is a hallmark of adaptation to the host
during chronic bacterial infection. There is considerable
interest in slow-growing subpopulations of bacteria, termed
small colony variants (SCVs), due to their association with
persistent infections [1, 2]. The SCV variant is common to
diverse bacteria and is characterized by phenotypes includ-
ing reduced growth, increased biofilm production [3], anti-
biotic resistance and hyperpiliation. SCVs have been
described for a wide range of bacterial genera and species
including Staphylococcus aureus [4, 5], Staphylococcus epi-
dermidis [6], Streptococcus sp. [7, 8], Enterococcus [9], Liste-
ria [10], Burkholderia [11], Salmonella [12], Brucella [13],
Lactobacillus, Serratia and Neisseria [14]. In the case of
Pseudomonas aeruginosa, SCVs are commonly associated
with chronic infection of the lung in patients with cystic
fibrosis (CF) [15, 16].
P. aeruginosa is the major proven cause of mortality in
patients with CF and chronic infection leads to a progres-
sive decline in pulmonary function and inevitably respira-
tory failure [17–19]. Despite intensive anti-pseudomonal
chemotherapy greatly improving the prognosis for CF
patients [20], the current median age at death for CF
patients is around 30 years in developed countries [21].
The frequent failure of antibiotic therapy and host defences
to eradicate P. aeruginosa from the CF lung is thought to
be largely due to the increased antibiotic tolerance when
growing in the biofilm state and the appearance of mucoid
phenotypic variants that are a hallmark of adaptation in
the chronically infected lung. A further complicating factor
is the appearance of highly adherent SCVs that are adept
at biofilm formation [15, 22, 23]. P. aeruginosa SCVs may
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display high intracellular levels of c-di-GMP [23–27],
enhanced biofilm formation, high fimbrial expression,
repression of flagellar genes, resistance to phagocytosis and
enhanced antibiotic resistance. Most importantly, the
appearance of SCVs in the CF lung correlates with poor
clinical outcome [11, 28–31].
There are a range of genetic changes that have been
shown to be responsible for the phenotypic switch to the
SCV phenotype in P. aeruginosa, including mutations in
the Wsp system and yfiBNR operon that form part of the
c-di-GMP regulatory system in P. aeruginosa [26, 32–34].
However, identification of the major clinically relevant
pathways of conversion to the SCV phenotype is compli-
cated by the unstable phenotype displayed by many SCVs
with reversion to a normal colony phenotype frequently
observed, preventing successful comparative genetic stud-
ies on clinical SCVs and their closely related parent
strains. In S. aureus, which also forms clinically relevant
SCVs, recent work has shown that a reversible large-scale
chromosomal inversion is the genetic basis of the switch
between a normal colony and SCV isolated from the same
patient [35]. In addition, S. aureus SCVs, which are com-
monly isolated from the CF lung, are highly resistant to
oxidative stress, suggesting that conversion to the SCV
phenotype may be an adaptation to the environment in
chronically inflamed host tissue [36].
In the present study, we have attempted to determine the
genetic basis of phenotypic conversion from the mucoid to
the SCV phenotype for SCVs isolated from the chronic lung
infection model described by Bayes et al. [37]. For two
SCVs isolated from this work, we have shown through a
combination of single-molecule real-time (SMRT; Pacific
Biosciences) and Illumina sequencing that a large and stable
chromosomal inversion and associated truncation of a 16S
rRNA gene accompanies conversion to the SCV phenotype.
The phenotypic switch is characterized by transcriptional
changes to a large number of genes that most notably
include downregulation of several genes encoding metabolic
enzymes, DNA repair proteins and heat shock proteins and
upregulation of genes encoding proteins involved in the
response to oxidative stress. The absence of other obvious
genetic changes suggests that this chromosomal inversion
may be the genetic basis of conversion to the SCV
phenotype.
RESULTS
P. aeruginosa SCVs are commonly isolated from patients
with CF and have been isolated in vitro as well as from
experimental infection models following aminoglycoside
treatment [16, 28]. Bayes et al. describe the isolation and
partial characterization of SCVs isolated from a chronic
murine P. aeruginosa lung infection model [37]. In this
model, animals were inoculated with P. aeruginosa strain
NH57388A (NHMuc), a mucoid clinical isolate, embedded
in agar beads. NHMuc has a known mutation in the gene
encoding the anti-sigma factor MucA, which results in
alginate overproduction [38, 39]. Recovered bacteria from
lung homogenate samples display two distinct colony mor-
phologies: typical large mucoid colonies identical in mor-
phology to the inoculating strain and SCVs. Mucoid
colonies were evident after 24 h of growth on agar plates at
37

C with SCVs visible only after 48 h of growth on agar
plates [37].
To understand the genetic basis of this phenotypic change,
we initially performed Illumina HiSeq whole-genome
sequencing and genomic comparison between NHMuc and
two separate SCVs (SCVJan and SCVFeb) isolated from
independent in vivo experiments. However, despite their
gross phenotypic differences, this analysis failed to identify
any genetic differences between the SCVs and the parent
strain.
Next, we used the ultra-long reads produced by SMRT Pac-
Bio sequencing to attempt to identify any large-scale
genome rearrangements that could drive conversion to the
SCV phenotype. Using this technique we identified a large-
scale genomic inversion accompanying conversion from the
parent mucoid to SCV phenotype in both SCVJan and
SCVFeb. Closer inspection of the genome sequence identi-
fied the start and end points of the inversion, which for
both SCVJan and SCVFeb begins at the first rRNA operon
(0.72 Mbp) and ends at the third rRNA operon (5.21 Mbp).
Exact chromosomal breakpoints were identified in the cor-
responding 16S rRNA genes by performing a MAUVE
breakpoint analysis (Fig. 1). Furthermore, genome analysis
revealed a 250 bp shortened 16S rRNA gene (16St) in both
SCV strains, which is reflected in the reduced genome sizes
of the SCVs (SCVJan 6 213 026 bp, SCVFeb 6 213 029 bp;
Fig. 2a) compared to the parent strain, NHmuc
(6 213 276 bp; Fig. 2b). There were no further differences in
the number of protein coding genes (5619), rRNAs (12) or
tRNAs (57) between SCVs and the parent strain. No SNPs
could be identified in protein coding genes. A similar
genome inversion was not identified (using a PCR-based
IMPACT STATEMENT
Chronic lung infection with Pseudomonas aeruginosa is
the major proven cause of mortality in patients with cys-
tic fibrosis. This is despite the use of aggressive antibiotic
therapy, which although effective in managing infection,
frequently fails to eradicate P. aeruginosa. Adaptation to
the lung is associated with the appearance of small col-
ony variants (SCVs), which are highly adherent and adept
at forming biofilms. Here we show that SCVs isolated
from the murine lung during chronic infection, and in the
absence of antibiotic therapy, show transcriptional
changes that enhance the oxidative stress response and
increase virulence. Sequencing of the genomes of the
SCVs and parent strain shows that the SCVs contain a
large genomic inversion relative to the parent strain.
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strategy) in a mucoid strain (NHMucJan) that was pheno-
typically identical to the parent strain (NHMuc) and iso-
lated from the same chronic infection model as SCVJan
(Fig. S1, available in the online version of this article). Inter-
estingly, comparison of the SCVJan and SCVFeb genomes
with that of an SCV (SCV20265) isolated from a CF patient
[40, 41], which has recently been sequenced by PacBio
sequencing, revealed an almost identical chromosomal
inversion. However, in SCV20265 the inversion was not
accompanied by truncation of the 16S rRNA gene in the
third rRNA operon (Fig. 1).
Transcriptional and phenotypic changes on
conversion to the SCV phenotype
To determine the transcriptional changes associated with
conversion to the SCV phenotype, we performed RNA
sequencing (RNA-Seq) analysis of the parent strain,
NHMuc, and two SCV strains grown in Lysogeny broth
(LB). Initial analysis showed that SCVJan and SCVFeb
have highly similar gene expression profiles that are dis-
tinct from that of NHMuc. RNA-Seq data for all strains
were collected in triplicate and data for SCVJan and
SCVFeb were combined to compare with NHMuc. Relative
Fig. 1. A common large-scale chromosomal inversion in three P. aeruginosa strains is the genetic basis for conversion to the SCV phe-
notype. From top to bottom strains NHMuC, SCVJan, SCVFeb and SCV20265 are displayed. Dashed lines indicate the inversion break-
points present in the 16S rRNA genes. An inversion with highly similar breakpoints is present in the genome of strain SCV20265, an
SCV isolated from a patient with CF. Within strains SCVJan and SCVFeb, a unique truncated version of the 16S rRNA gene (16St) could
be resolved, which could not be detected in strain SCV20265.
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to NHMuc, 190 genes showed >2-fold upregulation and
364 genes showed >2-fold downregulation in SCVJan/
SCVFeb (Table S1). Interestingly, the transcriptional
changes associated with genomic inversion and that drive
conversion to the SCV phenotype are not restricted to
genes close to or within the inversion breakpoints, with
major upregulated and downregulated genes distributed
relatively evenly throughout the genome (Fig. 3).
Major functional classes of genes downregulated in SCVJan/
SCVFeb include those involved in energy metabolism,
amino acid and protein biosynthesis, DNA replication and
recombination, and cell wall/lipopolysaccharide/capsule
biosynthesis, which together are consistent with the slow
growth rate observed for SCVs. Notably, genes encoding
heat shock proteins and other molecular chaperones (IbpA,
GrpE, HtpG, ClpB, DnaK, GroES, DnaJ and ClpX) are
highly represented among the most strongly downregulated
genes in the SCVs (Table 1). Conversely, genes that function
in the response to oxidative stress and those that encode
secreted virulence factors are largely upregulated in
SCVJan/SCVFeb. Indeed, five of the ten most highly upreg-
ulated genes in SCVJan/SCVFeb are those associated with
the response to oxidative stress (Table 2). Highly upreg-
ulated oxidative stress genes include katA [41], which enco-
des the major catalase of P. aeruginosa, ahpB, ahpC and
ahpF [42, 43], which encode subunits of alkyl hydroperox-
ide reductase, and trxB2, which encodes thioredoxin reduc-
tase 2 [44, 45]. Consistent with the observed transcriptional
changes, catalase activity was strongly increased in SCVJan
relative to NHMuc (Fig. 4a).
Genes encoding a number of secreted virulence factors
such as the proteases LasA, LasB and AprA, the frucose-
binding lectin LecB [46] and the chitin binding protein
CbpD and chitinase ChiC [47] were also highly upreg-
ulated. Similarly, genes encoding hydrogen cyanide syn-
thase and a number of enzymes that function in phenazine
biosynthesis are also upregulated (Table S1) [25, 48–51].
Phenazines have previously been shown to enhance killing
of Caenorhabditis elegans by P. aeruginosa [52]. The
apparent increase in the production of virulence factors by
SCVJan/SCVFeb relative to NHMuc suggests increased vir-
ulence of the SCV. To directly test this we used an infec-
tion model based on infection of the murine macrophage
cell line J774A.1. Cell death of J774A.1 through lactate
Fig. 2. Chromosomal maps of P. aeruginosa NHmuc (a) and SCVJan/SCVFeb (b). The circular genomes of both strains are shown.
Genomes of both SCV strains are 250 bp smaller than the parental strain NHmuc. Exact genome sizes are given in the lower left cor-
ner. In blue (circle 1) genes lying on the forward strand are shown and in red (circle 2) those on the reverse strand. In circle 3 tRNA
genes are shown in brown, often clustered together with green rRNA genes, which have been additionally marked by vertical arrows.
The red arrow shows the transposition of rRNA operon 3 in addition to that of a large tRNA region (green ellipse) due to the described
chromosomal inversion. Circle 4 shows the GC content, whereas in circle 5 a GC skew is shown. Numbers of coding sequences, rRNAs,
tRNAs and non-coding RNAs are identical in all strains (upper right corner according to GenBank submission).
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dehydrogenase (LDH) release was measured 4 and 10 h
after infection with NHMuc and SCVJan. At 4 h, levels of
LDH release were similar for NHMuc and SCVJan,
whereas at 10 h LDH release was significantly increased for
SCVJan (96 vs 38%, P<0.0001; Fig. 4b). To determine if
the increased virulence of the SCV observed against a
murine cell line translated to increased virulence in an ani-
mal model of infection, we used an invertebrate model of
infection using the larva of the wax moth Galleria mello-
nella. Similar to the macrophage infection assay, SCVJan
displayed increased virulence in the G. mellonella infection
model. Mortality of larvae was measured 24, 48 and 72 h
after infection. No significant differences in mortality were
detected at 24 or 48 h, whereas at 72 hmortality was 86
and 63% (P<0.04) for SCVJan- and NHMuc-infected lar-
vae, respectively (Fig. 4c). Data from both infection models
indicate that SCVJan shows increased virulence, relative to
NHMuc, which is consistent with the phenotype of SCVs
obtained from the human host [29, 53].
DISCUSSION
In this work we show that P. aeruginosa SCVs isolated from
a chronic murine lung infection model display a general
upregulation of virulence-associated genes, relative to the
mucoid parent strain, and increased virulence, which may
begin to explain the link between the appearance of SCVs in
chronic lung infection and the associated decline in lung
function [54]. In addition, the immediate upregulation of
genes that mediate the response to oxidative stress suggests
why the isolated SCVs are rapidly selected for in a chronic
infection model in which the host immune system is
strongly activated.
A key strength of our study was the availability of both the
parent strain used to establish infection in a chronic infec-
tion model and the derived SCVs that evolved during infec-
tion. This allowed for a meaningful comparative genetic
analysis to be performed to probe the genetic changes that
occurred on conversion to the SCV phenotype. Surprisingly,
SNPs and short insertions and deletions (indels) were not
identified in the SCV genome by Illumina sequencing, and
SMRT sequencing was subsequently used to show that the
two sequenced SCVs carried a large genomic inversion
within 16S rRNA genes. Interestingly, the transcriptional
changes associated with genomic inversion are not restricted
to genes close to or within the inversion breakpoints, but
distributed relatively evenly throughout the genome. Instead
the major changes in gene expression are largely restricted
to specific functional classes of genes including those that
mediate the response to oxidative stress, virulence, DNA
repair and recombination, the chaperone network and
metabolism. This global rewiring of the cellular transcrip-
tomic output results in concerted transcriptional changes to
these normally differentially regulated genes. However, the
mechanisms that underlie these transcriptional changes are
not clear. A study in Escherichia coli suggested that posi-
tional effects on gene expression may be due to local differ-
ences in chromosomal structuring and organization, with
DNA gyrase playing an important role at certain high-activ-
ity locations [55]. Further studies will be needed to clarify
such positional effects on gene expression in the SCV
studied here.
Other large-scale genome rearrangements including large
chromosomal inversions have previously been described in
P. aeruginosa, but these were not associated with conver-
sion to the SCV phenotype [56]. A reversible genomic
Fig. 3. Global changes in gene transcription on conversion to the SCV phenotype. Fold-changes in gene expression for SCVJan/Feb
relative to NHMuc are shown in the context of the NHMuc genome. Breakpoints that define the genomic inversion present in SCVJan
and SCVFeb are indicated by red rectangles.
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inversion has also recently been shown to mediate the
reversible conversion between normal colony and SCV
phenotypes in S. aureus [35]. However, in the case of the
SCVs isolated in our work, the SCV phenotype is stable
and revertants to the parent phenotype were not observed.
A possible explanation for this observation is that a num-
ber of genes encoding proteins involved in DNA repair
and recombination, including RecA, are downregulated in
the SCV relative to the parent strain (Table 1).
In conclusion, we have shown that a P. aeruginosa SCV that
originated in the lungs of an animal with chronic coloniza-
tion may result from a large chromosomal inversion and
associated truncation of an rRNA gene. Conversion to the
SCV phenotype was associated with large-scale transcrip-
tional changes and increased virulence.
METHODS
Genome assembly and annotation
Purified bacterial genomic DNA was prepared for sequenc-
ing on an Illumina HiSeq using Qiagen DNeasy Blood and
Tissue Kit as per the manufacturer’s protocol. Sequencing
and initial bioinformatics were performed in the Centre for
Genomic Research, University of Liverpool. Sequencing
reads were mapped to the corresponding reference genome
(annotated NH strain). SMRTbell template libraries were
prepared according to the instructions from Pacific Bioscien-
ces, following the Procedure and Checklist Greater than
10 kb Template Preparation and Sequencing. Briefly, for
preparation of 10 kb libraries, ~10 µg of genomic DNA iso-
lated from SCVJan, SCVFeb and NHmuc was sheared using
g-tubes from Covaris according to the manufacturer’s
instructions. In total, 5–10 µg of sheared genomic DNA was
end-repaired and ligated overnight to hairpin adapters apply-
ing components from the DNA/Polymerase Binding Kit P4
from Pacific Biosciences. Reactions were carried out accord-
ing to the manufacturer¢s instructions. SMRTbell template
was treated with exonuclease for removal of incompletely
formed reaction products. Conditions for annealing of
sequencing primers and binding of polymerase to purified
SMRTbell template were assessed with the Calculator in RS
Remote (Pacific Biosciences). SMRT sequencing was carried
out on the PacBio RSII (Pacific Biosciences) taking one
180min movie for each SMRT cell. In total six, six and five
SMRT cells were run respectively. Data from each SMRT cell
were assembled independently using the ‘RS_HGAP_Assem-
bly.3’ protocol included in SMRTPortal version 2.3.0 using
default parameters. Each assembly revealed the fully resolved
chromosome in one single contig. Each chromosome was cir-
cularized independently; in particular, artificial redundancies
at the ends of the contigs were removed and all chromosomes
were additionally adjusted to dnaA as the first gene. The
validity of each assembly was checked using the ‘RS_Bridge-
mapper.1’ protocol. For the purpose of this study, it has been
confirmed for each of the (repetitive) rRNA operons that
enough uniquely mapping long read exists spanning the
whole repeat structure. Finally, each genome was error-cor-
rected by a mapping of Illumina reads (paired-end reads,
100 bp) onto finished genomes using Burrows–Wheeler
Transform (BWA) [57] with subsequent variant calling using
VarScan [58]. A consensus concordance of QV60 could be
confirmed for all of the three genomes. Finally, all genomes
Fig. 4. Phenotypic characterization of SCVJan. (a) Catalase activity
assay demonstrating a marked increase in catalase activity in the SCV
as compared to the NH parent strain. (b) Percentage lactate dehydro-
genase (LDH) released from a macrophage cell line with comparison
between NHMuc and SCVJan over a 4 and 10 h time period. (c) Galleria
mellonella larvae survival over time when infected with the NHMuc
and SCVJan strains monitored over 72 h.
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were annotated using Prokka 1.8 [59]. All genome sequences
were deposited in NCBI GenBank under accession numbers
CP013477, CP013478 and CP013479. Illumina short read
data have been deposited at the EMBL-EBI ENA database
under study number PRJEB12456. The shortened 16S rRNA
gene for strains SCVJan and SCVFeb was confirmed by Pac-
Bio assembly as well as BWA mapping of Illumina reads
against the final chromosome showing uniquely mapped
reads only at that genome position (data not shown).
Genomemaps were created using DNAplotter65 [60].
Transcriptome analysis
RNA isolation of the samples was performed in triplicate.
Bacterial suspensions were grown to early stationary phase to
an OD600 of 1.8 in LB at 37

C in a shaking incubator. Then,
2ml of each suspension was pelleted at 12 000 g for 10min.
RNA was extracted from samples using a bead beating/chlo-
roform extraction method as previously described [61]. The
samples were digested with DNAse I for 1 h. Bacterial RNA
was enriched using MICROBEnrich (Life Technologies) as
per the suggested protocol. rRNA was depleted using Ribo-
Zero Magnetic Gold Kit (Epidemiology; Epicentre) as per the
manufacturer’s protocol. The precipitated sample was resus-
pended in 20 µl of RNAse-free water. The concentration of
RNA was initially determined using Nanodrop followed by
an Agilent Bioanalyser. cDNA was generated by using the
methods from the Superscript Double-Stranded cDNA Syn-
thesis Kit (Invitrogen) as per themanufacturer’s instructions.
Table 1. Highly downregulated genes in SCVs relative to NHMuc
Gene ID Fold change* P† Protein description PAO1 gene ID
NHmuc_01025  75 2.610 11 Putative acetyltransferase PA4364
mexC  53 1.110 11 RND multidrug efflux fusion protein MexC PA4599
ibpA  31 1.110 7 Heat-shock protein IbpA PA3126
algD  30 1.010 9 GDP-mannose 6-dehydrogenase AlgD PA3540
NHmuc_05385  29 8.510 8 17 kDa surface antigen PA5182
NHmuc_04138  29 1.310 10 Periplasmic metal-binding protein PA3520
grpE  25 1.210 7 Heat shock protein GrpE PA4762
htpG  23 3.610 7 Heat shock protein 90 PA1596
NHmuc_0100  23 1.810 5 Hypothetical, unclassified, unknown
clpB  21 6.510 6 ClpB protein PA4542
nfxB  21 3.710 7 Transcriptional regulator NfxB PA4600
fsxA  18 7.910 8 FxsA protein PA4387
NHmuc_04950  18 3.310 6 Molecular chaperone DnaK PA4761
NHmuc_05744  17 5.810 5 Putative lipoprotein PA5526
dapB  17 2.810 6 Dihydrodipicolinate reductase PA4759
hslV  17 4.110 7 ATP-dependent protease subunit PA5053
NHmuc_01173  16 4.710 6 Hypothetical protein PA2756
NHmuc_01024  16 6.110 7 Putative transporter PA4365
NHmuc_04180  16 3.310 6 Recombinase A PA3617
mexD  15 9.510 7 RND multidrug efflux transporter MexD PA4598
NHmuc_04776  15 6.110 6 PAS/PAC sensor signal transduction histidine kinase PA4197
rsmA  15 7.510 4 Carbon storage regulator PA0905
NHmuc_01174  14 3.310 7 Hypothetical protein PA0737
NHmuc_01594  13 2.110 5 Putative oxidoreductase PA1137
mucA  13 7.410 5 Anti-sigma factor MucA PA0763
NHmuc_03262  12 2.510 9 Hypothetical protein PA3505
NHmuc_04386  12 6.810 5 Surface antigen PA3819
amrZ  12 3.010 5 Alginate and motility regulator Z PA3385
glnA  12 5.810 6 Gutamine synthetase PA5119
groES  12 3.910 5 Co-chaperonin GroES PA4386
dnaJ  12 7.510 5 Chaperone protein DnaJ PA4760
algU  11 1.810 4 RNA polymerase sigma factor AlgU PA0762
clpX  11 4.510 4 ATP-dependent protease subunit ClpX PA1802
NHmuc_04521  11 1.910 6 Periplasmic ligand-binding sensor PA3952
*The magnitude of gene expression (fold change) was determined by comparing transcription in three replicates of NH with that in three replicates
each of the two SCV strains.
†P-values were assessed by performing an EDGE test using CLC software.
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Transcriptome analysis was performed using CLC work-
bench version 7.0 and significantly upregulated and downre-
gulated genes in SCVJan/SCVFeb versus NHMuc were
identified using the CLC software package. Transcriptome
data were deposited at the EMBL-EBI ENA database under
study number PRJEB12456.
PCR
Genomic DNA was extracted from 1.5ml of bacterial culture
using the GenElute Bacterial Genomic DNA Kit (Sigma).
Extraction was performed following the manufacturer’s rec-
ommendations and DNA was eluted into 100 µl of Elute
Solution. PCR detection of the inversion was performed with
KAPA polymerase (KAPA Long-range HotStart PCR Kit;
KAPA Biosystems) following the manufacturer’s protocol.
Two sets of primers were used: birA-F/yedZ-R and birA-F/
tyrZ-R (birA-F: CTCACCGGAGTGGAATC, yedZ-R:
TGAGCGCTTACTGCGTGTTCATCCTGG and tyrZ-R:
CCATACCGTGCTTATTAATAAGC) with the genomic
DNAs of the mucoid and SCV strains recovered from ani-
mals amplifying a fragment of 6262 or 6960 bp, respectively.
Galleria mellonella infection model
Larvae were stored on wood chips at 4

C. Overnight cultures
of bacterial strains were grown in LB, diluted 1 : 100 in the
same medium and grown to an OD600 of 0.3–0.4 as previ-
ously described [62, 63]. Cultures were centrifuged and pel-
lets were washed twice and resuspended in 10mM PBS to an
Table 2. Highly upregulated genes in SCVs relative to NHMuc
Gene ID Fold change* P† Protein description
NHmuc_04720 62 3.210 16 Hypothetical protein
trxB2 55 4.010 16 Thioredoxin reductase 2
NHmuc_01300 35 3.710 15 Putative alkyl hydroperoxide reductase
NHmuc_02350 28 1.410 26 Putative acyl carrier protein
ahpF 28 8.410 13 Alkyl hydroperoxide reductase subunit F
kata 23 7.110 10 Catalase
NHmuc_03862 20 6.910 21 Putative ankyrin domain-containing protein
NHmuc_03863 19 1.810 18 Putative hydrolase
NHmuc_00257 19 1.410 12 Putative CBS domain protein
ahpC 18 9.010 8 Alkyl hydroperoxide reductase subunit C
chiC 17 1.510 9 Chitinase
NHmuc_04185 17 6.710 6 RNA polymerase sigma factor RpoS
aprA 12 5.110 8 Alkaline metalloproteinase
NHmuc_04924 11 3.210 16 CsbD family protein
NHmuc_04718 11 1.510 11 Hypothetical protein
NHmuc_04925 11 2.210 8 Transport-associated
NHmuc_00127 10 5.910 7 Putative haemolysin
Snr1 10 4.910 7 Cytochrome c Snr1
lecB 9 5.910 8 Fucose-binding lectin PA-IIL
NHmuc_03413 8 9.110 15 Phage terminase, small subunit
katB 8 9.110 6 Catalase
NHmuc_04074 8 2.210 12 Leucyl-tRNA synthetase
phzG2_2 7 3.310 6 Pyridoxamine 5¢-phosphate oxidase
NHmuc_03358 7 2.010 8 Putative protein associated inclusion bodies
phzE1_1 7 3.210 6 Phenazine biosynthesis protein PhzE
NHmuc_00055 7 6.110 7 Hypothetical protein
NHmuc_01628 7 1.310 8 Hypothetical protein
cbpD 7 4.110 6 Chitin-binding protein CbpD
NHmuc_00546 6 2.010 3 LysR transcriptional regulator
rhlR 6 1.210 4 Transcriptional regulator RhlR
gcdH 6 4.310 5 Glutaryl-CoA dehydrogenase
NHmuc_01422 6 4.110 4 Putative DNA-binding stress protein
NHmuc_04078 6 1.510 10 Oxidoreductase probably involved in sulfite reduction
rsaL 6 1.210 2 Regulatory protein RsaL
*The magnitude of gene expression (fold change) was determined by comparing transcription in three replicates of NH with that in three replicates
each of the two SCV strains.
†P-values were assessed by performing an EDGE test using CLC software.
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OD600 of 0.1. Serial 10-fold dilutions were made in PBS. Five-
microlitre aliquots of the serial dilutions were injected using a
Hamilton syringe into G. mellonella larvae, via the hindmost
left proleg as previously described [64]. Ten larvae were
injected per dilution for each Pseudomonas strain tested. Lar-
vae were incubated in 10 cm plates at 37

C and the number
of dead larvae was scored 1–4 days after infection. For each
strain, data from three independent experiments were com-
bined. Larvae were considered dead when they displayed no
movement in response to touch. A negative control was used
in each experiment to monitor the killing due to physical
injury or infection by pathogenic contaminants. Time to
death was monitored every 24 h after infection. In any
instance where more than one control larvae died in any
given experiment, the data from infected larvae were
not used.
LDH release/cytotoxicity assay
To investigate the effect of the P. aeruginosa strains on mac-
rophages, we infected the J774A.1 cells with NH and SCV.
Bacteria were grown for 17 h to stationary phase in LB at
37

C. Immediately prior to infection, the bacteria were
diluted to exponential growth phase with culture medium
lacking phenol red and the concentration was determined by
measuring the optical density at 600 nm. Cells were grown,
washed and infected as previously documented [65]. Cells
were infected with test organisms and incubated for 4 and
10 h. LDH release was determined using the Cytotox 96 cyto-
toxicity assay kit (Promega) as per the manufacturer’s
protocol.
Catalase activity assay
Overnight cultures of bacterial strains were grown in LB,
diluted 1 : 100 in the samemedium and grown to an OD600 of
0.4. Catalase standards were prepared as per the manufac-
turer’s protocol using the OxiSelect Catalase Activity Assay
Kit, Colorimetric (Cell Biolabs). In total, 20 µl of each serial
dilution of overnight culture was added to three wells in a 96-
well plate to allow for average readings for each sample. Plate
absorbance was read at 520 nm using a FLUOstar Optima
plate reader (BMGUK).
Accessibility of biological resources
SCVs used in this study have been deposited at DSMZ
under DSM 100776–100778.
Funding information
This work was funded by an MRC SCP3 fellowship grant G1000419,
Welcome Trust grant 201505/Z/16/Z and by grant 8000-105-3 of the
German Federal Ministry of Science and Education through the Ger-
man Centre of Infection Research (DZIF) to J. O. We thank Simone
Severitt and Nicole Mrotzek at the Leibniz Institute DSMZ, Germany,
for excellent technical assistance.
Author Contributions
S. I., D. W., B. B. and J. O. conceived and designed the experiments and
analysis. S. I., B. B., C. S. and A. S. performed the experiments. S. I.,
B. B., J. P. R. C. and A. J. R. analysed the data. T. J. E. and H. K. B. sup-
plied novel reagents. D. W. and S. I. wrote the manuscript.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Data Bibliography
Eckweiler D, Bunk B, Spröer C, Overmann J, H€aussler S. Complete
Genome Sequence of Small-Colony Variant SCV20265. DDBJ/EMBL/
GenBank no. CP.
References
1. Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P et al.
Small colony variants: a pathogenic form of bacteria that facili-
tates persistent and recurrent infections. Nat Rev Microbiol 2006;
4:295–305.
2. Grant SS, Hung DT. Persistent bacterial infections, antibiotic toler-
ance and the oxidative stress response. Virulence 2013;4:273–
283.
3. Deziel E, Comeau Y, Villemur R. Initiation of biofilm formation by
Pseudomonas aeruginosa 57RP correlates with emergence of
hyperpiliated and highly adherent phenotypic variants deficient in
swimming, swarming, and twitching motilities. J Bacteriol 2001;
183:1195–1204.
4. Mirani ZA, Aziz M, Khan SI. Small colony variants have a major
role in stability and persistence of Staphylococcus aureus biofilms.
J Antibiot 2015;68:98–105.
5. Brouillette E, Martinez A, Boyll BJ, Allen NE, Malouin F. Persis-
tence of a Staphylococcus aureus small-colony variant under anti-
biotic pressure in vivo. FEMS Immunol Med Microbiol 2004;41:35–
41.
6. Maduka-Ezeh AN, Greenwood-Quaintance KE, Karau MJ, Berbari
EF, Osmon DR et al. Antimicrobial susceptibility and biofilm for-
mation of Staphylococcus epidermidis small colony variants asso-
ciated with prosthetic joint infection. Diagn Microbiol Infect Dis
2012;74:224–229.
7. Allegrucci M, Sauer K. Formation of Streptococcus pneumoniae
non-phase-variable colony variants is due to increased mutation
frequency present under biofilm growth conditions. J Bacteriol
2008;190:6330–6339.
8. Zbinden A, Quiblier C, Hernandez D, Herzog K, Bodler P et al.
Characterization of Streptococcus tigurinus small-colony variants
causing prosthetic joint infection by comparative whole-genome
analyses. J Clin Microbiol 2014;52:467–474.
9. Wellinghausen N, Chatterjee I, Berger A, Niederfuehr A, Proctor
RA et al. Characterization of clinical Enterococcus faecalis small-
colony variants. J Clin Microbiol 2009;47:2802–2811.
10. Rea R, Hill C, Gahan CG. Listeria monocytogenes PerR mutants
display a small-colony phenotype, increased sensitivity to hydro-
gen peroxide, and significantly reduced murine virulence. Appl
Environ Microbiol 2005;71:8314–8322.
11. Pinto-de-Oliveira A, Coutinho CP, Ramos CG, Sousa SA, de
Carvalho CCCR et al. 109 the Burkholderia cepacia small colony
variants (SCV) are a more pathogenic bacterial form that may
facilitate persistent respiratory infections in CF patients. J Cyst
Fibros 2013;12:S76.
12. Cano DA, Pucciarelli MG, Martínez-Moya M, Casadesús J, García-
del Portillo F. Selection of small-colony variants of Salmonella
enterica serovar typhimurium in nonphagocytic eucaryotic cells.
Infect Immun 2003;71:3690–3698.
13. Jacob J, Hort GM, Overhoff P, Mielke ME. In vitro and in vivo char-
acterization of smooth small colony variants of Brucella
abortus S19. Microbes Infect 2006;8:363–371.
14. Morton HE, Shoemaker J. The identification of neisseria gonor-
rhoeae by means of bacterial variation and the detection of small
colony forms in clinical material. J Bacteriol 1945;50:585–587.
15. H€aussler S, Ziegler I, Löttel A, von Götz F, Rohde M et al. Highly
adherent small-colony variants of Pseudomonas aeruginosa in cys-
tic fibrosis lung infection. J Med Microbiol 2003;52:295–301.
Irvine et al., Microbial Genomics 2019;5
9
16. Evans TJ. Small colony variants of Pseudomonas aeruginosa in
chronic bacterial infection of the lung in cystic fibrosis. Future
Microbiol 2015;10:231–239.
17. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009;373:
1891–1904.
18. Li Z, Kosorok MR, Farrell PM, Laxova A, West SE et al. Longitudi-
nal development of mucoid Pseudomonas aeruginosa infection and
lung disease progression in children with cystic fibrosis. JAMA
2005;293:581.
19. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL.
Pseudomonas aeruginosa and other predictors of mortality and
morbidity in young children with cystic fibrosis. Pediatr Pulmonol
2002;34:91–100.
20. Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O et al. Adap-
tation of Pseudomonas aeruginosa to the cystic fibrosis airway: an
evolutionary perspective. Nat Rev Microbiol 2012;10:841–851.
21. CF Registry. Annual Data Reports - Cystic Fibrosis Trust.
22. Webb JS, Lau M, Kjelleberg S. Bacteriophage and phenotypic vari-
ation in Pseudomonas aeruginosa biofilm development. J Bacteriol
2004;186:8066–8073.
23. H€aussler S. Biofilm formation by the small colony variant pheno-
type of Pseudomonas aeruginosa. Environ Microbiol 2004;6:546–
551.
24. Starkey M, Hickman JH, Ma L, Zhang N, de Long S et al.
Pseudomonas aeruginosa rugose small-colony variants have
adaptations that likely promote persistence in the cystic fibrosis
lung. J Bacteriol 2009;191:3492–3503.
25. Wang D, Dorosky RJ, Han CS, Lo CC, Dichosa AE et al. Adaptation
genomics of a small-colony variant in a Pseudomonas chlororaphis
30-84 biofilm. Appl Environ Microbiol 2015;81:890–899.
26. Malone JG, Jaeger T, Spangler C, Ritz D, Spang A et al. YfiBNR
mediates cyclic di-GMP dependent small colony variant formation
and persistence in Pseudomonas aeruginosa. PLoS Pathog 2010;6:
e1000804.
27. Blanka A, Düvel J, Dötsch A, Klinkert B, Abraham WR et al. Con-
stitutive production of c-di-GMP is associated with mutations in a
variant of Pseudomonas aeruginosa with altered membrane com-
position. Sci Signal 2015;8:ra36.
28. Wolter DJ, Emerson JC, McNamara S, Buccat AM, Qin X et al.
Staphylococcus aureus small-colony variants are independently
associated with worse lung disease in children with cystic fibro-
sis. Clin Infect Dis 2013;57:384–391.
29. von Götz F, H€aussler S, Jordan D, Saravanamuthu SS,
Wehmhöner D et al. Expression analysis of a highly adherent and
cytotoxic small colony variant of Pseudomonas aeruginosa isolated
from a lung of a patient with cystic fibrosis. J Bacteriol 2004;186:
3837–3847.
30. Besier S, Smaczny C, von Mallinckrodt C, Krahl A, Ackermann H
et al. Prevalence and clinical significance of Staphylococcus aureus
small-colony variants in cystic fibrosis lung disease. J Clin
Microbiol 2007;45:168–172.
31. Kahl B, Herrmann M, Everding AS, Koch HG, Becker K et al. Per-
sistent infection with small colony variant strains of Staphylococ-
cus aureus in patients with cystic fibrosis. J Infect Dis 1998;177:
1023–1029.
32. Deretic V, Govan JR, Konyecsni WM, Martin DW. Mucoid Pseudo-
monas aeruginosa in cystic fibrosis: mutations in the muc loci
affect transcription of the algR and algD genes in response to
environmental stimuli. Mol Microbiol 1990;4:189–196.
33. Hickman JW, Tifrea DF, Harwood CS. A chemosensory system
that regulates biofilm formation through modulation of cyclic
diguanylate levels. Proc Natl Acad Sci USA 2005;102:14422–
14427.
34. D’Argenio DA, Calfee MW, Rainey PB, Pesci EC. Autolysis and
autoaggregation in Pseudomonas aeruginosa colony morphology
mutants. J Bacteriol 2002;184:6481–6489.
35. Cui L, Neoh HM, Iwamoto A, Hiramatsu K. Coordinated phenotype
switching with large-scale chromosome flip-flop inversion
observed in bacteria. Proc Natl Acad Sci USA 2012;109:E1647–
E1656.
36. Painter KL, Strange E, Parkhill J, Bamford KB, Armstrong-James
D et al. Staphylococcus aureus adapts to oxidative stress by pro-
ducing H2O2-resistant small-colony variants via the SOS
response. Infect Immun 2015;83:1830–1844.
37. Bayes HK, Ritchie N, Irvine S, Evans TJ. A murine model of early
Pseudomonas aeruginosa lung disease with transition to chronic
infection. Sci Rep 2016;6:35838.
38. Hoffmann N, Rasmussen TB, Jensen PØ, Stub C, Hentzer M et al.
Novel mouse model of chronic Pseudomonas aeruginosa lung
infection mimicking cystic fibrosis. Infect Immun 2005;73:2504–
2514.
39. Boucher JC, Yu H, Mudd MH, Deretic V. Mucoid Pseudomonas aer-
uginosa in cystic fibrosis: characterization of muc mutations in
clinical isolates and analysis of clearance in a mouse model of
respiratory infection. Infect Immun 1997;65:3838–3846.
40. Eckweiler D, Bunk B, Spröer C, Overmann J, H€aussler S. Com-
plete genome sequence of highly adherent Pseudomonas aerugi-
nosa small-colony variant SCV20265. Genome Announc 2014;2:
e01232–13.
41. Lee JS, Heo YJ, Lee JK, Cho YH. KatA, the major catalase, is criti-
cal for osmoprotection and virulence in Pseudomonas aeruginosa
PA14. Infect Immun 2005;73:4399–4403.
42. Ochsner UA, Vasil ML, Alsabbagh E, Parvatiyar K, Hassett DJ.
Role of the Pseudomonas aeruginosa oxyR-recG operon in oxida-
tive stress defense and DNA repair: OxyR-dependent regulation of
katB-ankB, ahpB, and ahpC-ahpF. J Bacteriol 2000;182:4533–
4544.
43. Vinckx T, Matthijs S, Cornelis P. Loss of the oxidative stress regu-
lator OxyR in Pseudomonas aeruginosa PAO1 impairs growth
under iron-limited conditions. FEMS Microbiol Lett 2008;288:258–
265.
44. Chung JS, Noguera-Mazon V, Lancelin JM, Kim SK, Hirasawa M
et al. Interaction domain on thioredoxin for Pseudomonas aerugi-
nosa 5’-adenylylsulfate reductase. J Biol Chem 2009;284:31181–
31189.
45. Hishinuma S, Ohtsu I, Fujimura M, Fukumori F. OxyR is involved
in the expression of thioredoxin reductase TrxB in Pseudomonas
putida. FEMS Microbiol Lett 2008;289:138–145.
46. Tielker D, Hacker S, Loris R, Strathmann M, Wingender J et al.
Pseudomonas aeruginosa lectin LecB is located in the outer mem-
brane and is involved in biofilm formation. Microbiology 2005;151:
1313–1323.
47. Frederiksen RF, Paspaliari DK, Larsen T, Storgaard BG, Larsen
MH et al. Bacterial chitinases and chitin-binding proteins as viru-
lence factors. Microbiology 2013;159:833–847.
48. Mavrodi DV, Bonsall RF, Delaney SM, Soule MJ, Phillips G
et al. Functional analysis of genes for biosynthesis of pyocyanin
and phenazine-1-carboxamide from Pseudomonas aeruginosa
PAO1. J Bacteriol 2001;183:6454–6465.
49. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D. Pseudomonas aer-
uginosa pyocyanin is critical for lung infection in mice. Infect
Immun 2004;72:4275–4278.
50. Pessi G, Williams F, Hindle Z, Heurlier K, Holden MT et al. The
global posttranscriptional regulator RsmA modulates production
of virulence determinants and N-acylhomoserine lactones in
Pseudomonas aeruginosa. J Bacteriol 2001;183:6676–6683.
51. Sanchez P, Linares JF, Ruiz-Díez B, Campanario E, Navas A et al.
Fitness of in vitro selected Pseudomonas aeruginosa nalB and
nfxB multidrug resistant mutants. J Antimicrob Chemother 2002;
50:657–664.
52. Cezairliyan B, Vinayavekhin N, Grenfell-Lee D, Yuen GJ,
Saghatelian A et al. Identification of Pseudomonas aeruginosa phe-
nazines that kill Caenorhabditis elegans. PLoS Pathog 2013;9:
e1003101.
Irvine et al., Microbial Genomics 2019;5
10
53. Sabra W, Haddad AM, Zeng AP. Comparative physiological study
of the wild type and the small colony variant of Pseudomonas aer-
uginosa 20265 under controlled growth conditions. World J
Microbiol Biotechnol 2014;30:1027–1036.
54. Evans TJ. Small colony variants of Pseudomonas aeruginosa in
chronic bacterial infection of the lung in cystic fibrosis. Future
Microbiol 2015;10:231–239.
55. Bryant JA, Sellars LE, Busby SJ, Lee DJ. Chromosome position
effects on gene expression in Escherichia coli K-12. Nucleic Acids
Res 2014;42:11383–11392.
56. Klockgether J, Munder A, Neugebauer J, Davenport CF, Stanke F
et al. Genome diversity of Pseudomonas aeruginosa PAO1 labora-
tory strains. J Bacteriol 2010;192:1113–1121.
57. Li H, Durbin R. Fast and accurate short read alignment with Bur-
rows-Wheeler transform. Bioinformatics 2009;25:1754–1760.
58. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD et al. Var-
Scan 2: somatic mutation and copy number alteration discovery in
cancer by exome sequencing. Genome Res 2012;22:568–576.
59. Seemann T. Prokka: rapid prokaryotic genome annotation.
Bioinformatics 2014;30:2068–2069.
60. Carver T, Thomson N, Bleasby A, Berriman M, Parkhill J. DNA-
Plotter: circular and linear interactive genome visualization.
Bioinformatics 2009;25:119–120.
61. Lim YW, Schmieder R, Haynes M, Willner D, Furlan M et al.
Metagenomics and metatranscriptomics: windows on CF-associ-
ated viral and microbial communities. J Cyst Fibros 2013;12:
154–164.
62. Ramarao N, Nielsen-Leroux C, Lereclus D. The insect Galleria
mellonella as a powerful infection model to investigate bacterial
pathogenesis. J Vis Exp 2012:e4392.
63. Miyata S, Casey M, Frank DW, Ausubel FM, Drenkard E. Use of
the Galleria mellonella caterpillar as a model host to study the
role of the type iii secretion system in Pseudomonas aeruginosa
pathogenesis. Infect Immun 2003;71:2404–2413.
64. Jander G, Rahme LG, Ausubel FM. Positive correlation between
virulence of Pseudomonas aeruginosa mutants in mice and
insects. J Bacteriol 2000;182:3843–3845.
65. Hauser AR, Engel JN. Pseudomonas aeruginosa induces type-III-
secretion-mediated apoptosis of macrophages and epithelial cells.
Infect Immun 1999;67:5530–5537.
Irvine et al., Microbial Genomics 2019;5
11
Five reasons to publish your next article with a Microbiology Society journal
1. The Microbiology Society is a not-for-profit organization.
2. We offer fast and rigorous peer review – average time to first decision is 4–6 weeks.
3. Our journals have a global readership with subscriptions held in research institutions around
the world.
4. 80% of our authors rate our submission process as ‘excellent’ or ‘very good’.
5. Your article will be published on an interactive journal platform with advanced metrics.
Find out more and submit your article at microbiologyresearch.org.
